This post contains links to and excerpts from A comprehensive evaluation of standardized assessment tools in the diagnosis of fibromyalgia and in the assessment of fibromyalgia severity [PubMed Abstract] [Full Text HTML] [Full Text PDF]. Pain Res Treat 2012; 2012: 653714.
Here are some excerpts:
Fibromyalgia (FM) is one of the most challenging disorders
to manage. . . . This paper represents one author’s
review of the available literature and his recommendations
for current and future assessments to clinically diagnose FM
and measure the severity of FM symptoms in research to
enable development of new therapies and biomarkers. The
recommendations made in this paper are intended to be a
starting point for discussions in a group such as outcome
measures in rheumatology (OMERACT) rather than the
final articulation of standards to be used.
Recommended Assessment Instruments
The BPI is a powerful tool that has been adopted worldwide for clinical pain assessment, epidemiological studies, and studies of the effectiveness of pain treatment.
Charles S. Cleeland, Ph.D., Professor, Symptom Research
The Brief Pain Inventory User Guide Copyright 1991 Charles S. Cleeland, MD Anderson
In response to the US Food and Drug Administration (FDA) guidance for the pharmaceutical industry on the use of patient-reported outcome measures in medical product development to support labeling claims, we have prepared a BPI User’s Guide to document the BPI’s development and psychometric properties. The information offered therein addresses the recommendations in the FDA guidance and establishes the BPI’s adequacy as a measure to support medical product claims
Fibromyalgia Intensity Score
Jenkins Sleep Scale
MASQ: multiple abilities self-report questionnaire
A comprehensive evaluation of standardized assessment tools in the diagnosis of
fibromyalgia and in the assessment of fibromyalgia severity [PubMed Abstract] [Full Text HTML] [Full Text PDF]. Pain Res Treat 2012; 2012: 653714.